- Somanetics to Webcast Presentation on November 10, 2008 at 4:30 P.M. ET -
TROY, Mich., Nov. 3 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) today announced it will present at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York. William Iacona, Somanetics' chief financial officer, will make a 25-minute presentation on Monday, November 10, 2008 at 4:30 p.m. ET. The presentation will be webcast live. The webcast may be accessed by visiting the Investor Center section of Somanetics' website at http://www.somanetics.com . The presentation also will be archived on Somanetics' website for 30 days following the conference.
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System has a nearly 11-year market track record supported by more than 600 clinical references, and is used at nearly 700 U.S. hospitals. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit http://www.somanetics.com .
|SOURCE Somanetics Corporation|
Copyright©2008 PR Newswire.
All rights reserved